IRF1 and neoplasm: IRF1-AS1 (Lnc-SLC22A5-6) was found to act as a positive modulator of the IFN response in esophageal squamous cell carcinoma (ESCC), functioning as a tumor suppressor by regulating cell proliferation and apoptosis [29].